The biomechanics of the Reaching Movement in Friedreich Patients (Contributo in atti di convegno)

Type
Label
  • The biomechanics of the Reaching Movement in Friedreich Patients (Contributo in atti di convegno) (literal)
Anno
  • 2011-01-01T00:00:00+01:00 (literal)
Alternative label
  • Caimmi, M. and Gasperini, G. and Pedrocchi, N. and Malosio, M. and Vicentini, F. and Molinari Tosatti, L. and Molteni, F. (2011)
    The biomechanics of the Reaching Movement in Friedreich Patients
    in 11th Congress of the European Federation for Research in Rehabilitation, Riva del Garda (TN), Italy, 2011-26-28, May
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Caimmi, M. and Gasperini, G. and Pedrocchi, N. and Malosio, M. and Vicentini, F. and Molinari Tosatti, L. and Molteni, F. (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#titoloVolume
  • EFRR, Riva del Garda, Italy, 26-28 May 2011 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Nicola Pedrocchi (CNR-ITIA), Matteo Malosio (CNR-ITIA), Federico Vicentini (CNR-ITIA), Lorenzo Molinari Tosatti (CNR-ITIA), Caimmi Marco (Villa Beretta-Ospedale Valduce), Gasperini Marco (Villa Beretta-Ospedale Valduce), Molteni Franco (Villa Beretta-Ospedale Valduce) (literal)
Titolo
  • The biomechanics of the Reaching Movement in Friedreich Patients (literal)
Abstract
  • Friedreich ataxia (FRDA) is a progressive, autosomal recessive, degenerative disorder affecting multiple systems. The clinical features of FRDA are progressive ataxia, weakness, spasticity, sensory symptoms and cardiomyopathy. Upper-extremity movements against gravity are soon compromised and, consequently, the patient's autonomy is significantly reduced. Although there are no therapies proven to alter the inexorable decline seen in FRDA, a number of potential pharmacological and rehabilitation therapies have been proposed and a number of clinical trials are underway. Rehabilitation therapies usually focus on strategies and compensatory techniques for maintaining or improving a patient's ability to continue to participate in all environmental contexts for as long as possible. The challenge facing clinicians in evaluating the efficacy of such pharmacological and rehabilitative therapies is the accurate and efficient measurement of disease progression. A method to analyze the mechanisms leading to reaching movement inability in FPs is here presented. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it